Use access key #2 to skip to page content.
$2.35 0.00 (0.00%)
6/9/2008 4:00 PM

Encysive Pharmaceuticals, Inc. (ENCY.DL)

CAPS Rating:
No stars

A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.

View All Commentary (ENCY.DL)

Recs

0

Avatar sugardadE (79.43) Submitted: 8/25/07 6:53 PM : Outperform Start Price: $1.88 ENCY.DL Score: 32.60

Hit or miss, it's up to the FDA.

Report this Post Replies: 0 | Reply

Featured Broker Partners